Global diabetes cases on pace to soar to 1.3 billion people in the next 3 decades, new study finds
Retrieved on:
星期三, 七月 19, 2023
People, Moyamoya disease, Insulin, Obesity, Type 2 diabetes, Diet, Prevalence, Diabetes, Life, Health, Disability, Glucose, Stroke, Ageing, Type 1 and type 2 sequence, Research, Risk, Death, Type 2, Autoimmune disease, Tobacco, Paratriathlon, Global Burden of Disease Study, Environment, Disease, Geography, Pharmaceutical industry, Soft drink, Agriculture, Meat, Dietary supplement, Injury, Lancet
The Research Brief is a short take about interesting academic work.The big ideaThat is one of the key findings from our study on the global burden of diabetes recently published in The Lancet.
Key Points:
The Research Brief is a short take about interesting academic work.
The big idea
- That is one of the key findings from our study on the global burden of diabetes recently published in The Lancet.
- Our study included more than 27,000 data sources to produce estimates of diabetes prevalence, disability and deaths for 204 countries and territories from 1990 through 2021.
- Using a modeling tool that takes into account sociodemographic factors and obesity, we projected diabetes prevalence out to 2050.
- In 2021, obesity was the most important risk factor for Type 2 diabetes, accounting for more than half of disability and death from the disease.
Why it matters
- This compounds the stress of diabetes on health care systems, requiring more comprehensive screening and management.
- However, a study found that fewer than 1 in 10 people with diabetes in low- and middle-income countries have access to comprehensive diabetes treatment.
- Based on an abundance of research, the two primary drivers of the expected rise in diabetes cases will be aging and obesity.
What other research is being done
- Research shows that there are many complex social and economic dynamics at play when it comes to trying to live a healthy lifestyle.
- Low income, low education level and living in urban areas are all associated with a higher risk of developing Type 2 diabetes.